Beta-containing COVID-19 booster vaccine found to cross-neutralize

A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.

COVID-19 booster after Omicron: Are 3rd or 4th shots necessary?

Are Omicron-Targeted Boosters Worth It?

Vaccines, Free Full-Text

JCM, Free Full-Text

Dean Huang's Instagram, Twitter & Facebook on IDCrawl

Vaccines, Free Full-Text

Vaccines, Free Full-Text

Frontiers Viral vector and nucleic acid vaccines against COVID-19: A narrative review

Latest on Omicron Variant and COVID-19 Vaccine Protection – NIH Director's Blog

Vaccines, Free Full-Text

Vaccinating previously infected induces more potent antibodies less susceptible to escape from SARS-CoV-2 variants

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

Novavax on X: NEWS: Novavax Announces #COVID19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination / X

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice